LAM
DXCM icon

Lebenthal Asset Management’s DexCom DXCM Stock Holding History

Lebenthal Asset Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-940
Closed -$21K – 406
2016
Q3 		$21K Buy
+940
New +$20.9K ﹤0.01% 596

Other funds holding DXCM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Lebenthal Asset Management's DXCM Position: Q4 2016 in Review

Lebenthal Asset Management sold out of DexCom (DXCM) in Q4 2016, closing a stake of 940 shares — an estimated $21K sold.

Lebenthal Asset Management first reported a position in DXCM in Q3 2016 and held it in 1 quarter. The position peaked at $21K in Q3 2016. 316 funds tracked by Wall St. Rank hold DXCM as of Q4 2016.

  • Lebenthal Asset Management reported no remaining DexCom position as of Q4 2016 after selling out during the quarter.
  • Lebenthal Asset Management sold 940 DexCom shares in Q4 2016, an estimated $21K.
  • Lebenthal Asset Management first reported a position in DexCom in Q3 2016 and held it in 1 quarter.
  • Lebenthal Asset Management's DexCom position peaked at $21K in Q3 2016.
  • 316 funds tracked by Wall St. Rank held DexCom as of Q4 2016.

Based on Lebenthal Asset Management's 13F filing for Q4 2016, filed 15 Feb 2017.